PatientsVille.com Logo

PatientsVille

Lansoprazole Side Effects

Report Lansoprazole Side Effects

If you experienced any harmful or unwanted effects of Lansoprazole, please share your experience. This could help to raise awareness about Lansoprazole side effects, identify uknown risks and inform health professionals and patients taking Lansoprazole.

Examples: headache, dizziness


The most commonly reported Lansoprazole side effects are:
Bloated (31 reports)
Wind (22 reports)
Always Tired (18 reports)
Achng Back (17 reports)
Diarrhea (11 reports)
Stomach Ache (11 reports)
Anxiety (6 reports)
Hunger (6 reports)
Sweats (6 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Lansoprazole side effects . You can also compare Lansoprazole side effects or view FDA reports.

Lansoprazole Side Effects reported to FDA

The following Lansoprazole reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Lansoprazole on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 82 

Extra Dose Administered
on Feb 14, 2014 Female from US , 70 years of age, weighting 155.1 lb, was diagnosed with and was treated with Lansoprazole Dr Capsules 15mg Otc. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: extra dose administered. Lansoprazole Dr Capsules 15mg Otc dosage: N/A.
Associated medications used: Patient was hospitalized.

Colon Cancer
Patient was taking Lansoprazole. Patient felt the following Lansoprazole side effects: colon cancer on Feb 12, 2014 from JP Additional patient health information: Male , 73 years of age, was diagnosed with and. Lansoprazole dosage: 15 Mg, Qd.
Multiple prescriptions taken:

Dermatitis Exfoliative, Eczema, Lymphocytic Infiltration, Parakeratosis, Rash Erythematous, Skin Exfoliation
Adverse event was reported on Mar 04, 2014 by a Female taking Lansoprazole (Dosage: N/A) . Location: GB , 76 years of age, After Lansoprazole was administered, patient encountered several Lansoprazole side effects: dermatitis exfoliative, eczema, lymphocytic infiltration, parakeratosis, rash erythematous, skin exfoliation.
Multiple concurrent drugs taken:
  • Allopurinol
  • Aminophyline (aminophylline)
  • Dosulepin (dosulepin)
  • Furosemide (furosemide)
  • Indapamide (indapamide)
  • Novomix (insulin Aspart)
  • Ramipril (ramipril)
  • Salbutamol (salbutamol)
Patient was hospitalized.

Back Pain, Condition Aggravated, Hiatus Hernia, Palpitations
on Feb 10, 2014 Female from US , weighting 216.1 lb, was treated with Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: back pain, condition aggravated, hiatus hernia, palpitations. Lansoprazole dosage: N/A.
Associated medications used:


Hypomagnesaemia, Nausea, Tremor, Balance Disorder
on Feb 10, 2014 Female from US , 65 years of age, was treated with Lansoprazole. Patient felt the following Lansoprazole side effects: hypomagnesaemia, nausea, tremor, balance disorder. Lansoprazole dosage: N/A.
Multiple prescriptions taken: Patient was hospitalized.

Hypomagnesaemia, Tremor, Nausea, Balance Disorder
Patient was taking Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: hypomagnesaemia, tremor, nausea, balance disorder on Feb 12, 2014 from GB Additional patient health information: Female , 65 years of age, . Lansoprazole dosage: N/A.
Multiple concurrent drugs taken:
  • Ramipril (Ongoing.)
  • Loperamide (Ongoing)
Patient was hospitalized.

Chest Pain, Diarrhoea, Gastritis, Nausea, Proctitis
Adverse event was reported on Feb 11, 2014 by a Female taking Lansoprazole (Dosage: N/A) was diagnosed with and. Location: IT , 81 years of age, Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: chest pain, diarrhoea, gastritis, nausea, proctitis.

Haemorrhage, Haemoglobin Decreased, Rectal Haemorrhage, Vaginal Haemorrhage, Purpura, Melaena, Rash Erythematous, Rash Maculo-papular, Arthralgia
on Feb 07, 2014 Female from GB , 34 years of age, weighting 220.0 lb, was diagnosed with and was treated with Lansoprazole. Patient felt the following Lansoprazole side effects: haemorrhage, haemoglobin decreased, rectal haemorrhage, vaginal haemorrhage, purpura, melaena, rash erythematous, rash maculo-papular, arthralgia. Lansoprazole dosage: 30 Mg, Qd.
Multiple prescriptions taken:
  • Tranexamic Acid (1 Df, Qid)
  • Dexamethasone
  • Rituximab (375 Mg/m2, Bid)
  • Nplate (1 Mg/kg, Unk)
  • Immunoglobulins (1000 Mg, Qd)
  • Norethindrone (5 Mg, Tid)
  • Vincristine Sulfate
Patient was hospitalized.

Hepatitis Acute, Gamma-glutamyltransferase Increased, Blood Cholesterol Increased, Alanine Aminotransferase Increased
on Feb 07, 2014 Male from GB , 38 years of age, weighting 156.5 lb, was diagnosed with and was treated with Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: hepatitis acute, gamma-glutamyltransferase increased, blood cholesterol increased, alanine aminotransferase increased. Lansoprazole dosage: 15 Mg, Unk.

Hypomagnesaemia, Hypocalcaemia, Syncope, Asthenia
Patient was taking Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: hypomagnesaemia, hypocalcaemia, syncope, asthenia on Feb 07, 2014 from GB Additional patient health information: Male , 68 years of age, weighting 180.8 lb, was diagnosed with and. Lansoprazole dosage: 60 Milligram Daily;. Patient was hospitalized.

Hepatitis Acute, Gamma-glutamyltransferase Increased, Blood Cholesterol Increased, Alanine Aminotransferase Increased
Adverse event was reported on Feb 07, 2014 by a Male taking Lansoprazole (Dosage: N/A) was diagnosed with and. Location: GB , 38 years of age, weighting 156.5 lb, Patient felt the following Lansoprazole side effects: hepatitis acute, gamma-glutamyltransferase increased, blood cholesterol increased, alanine aminotransferase increased.
Multiple prescriptions taken:

Hepatitis Acute, Blood Cholesterol Increased
on Feb 06, 2014 Male from GB , 38 years of age, weighting 156.5 lb, was diagnosed with and was treated with Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: hepatitis acute, blood cholesterol increased. Lansoprazole dosage: N/A.
Multiple concurrent drugs taken:

Colon Cancer, Dermatitis Contact, Anaemia
on Mar 18, 2014 Female from JP , 76 years of age, was diagnosed with and was treated with Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: colon cancer, dermatitis contact, anaemia. Lansoprazole dosage: 15 Mg, Qd.
Associated medications used:
  • Adofeed Pap (160 Mg, 1 Days)
  • Loxoprofen /00890702/ (180 Mg, 1 Days)
  • Voltaren /00372302/ (25 Mg, 1 Days)
  • Rebamipide (300 Mg, 1 Days)
  • Elcitonin Inj. 20s Dispo (20 Iu, 1/week)
Patient was hospitalized.

Hypocalcaemia, Hypomagnesaemia, Syncope, Asthenia
Patient was taking Lansoprazole. Patient felt the following Lansoprazole side effects: hypocalcaemia, hypomagnesaemia, syncope, asthenia on Feb 05, 2014 from GB Additional patient health information: Male , 68 years of age, weighting 180.8 lb, was diagnosed with and. Lansoprazole dosage: N/A. Patient was hospitalized.

Purpura, Haemorrhage, Rash Erythematous, Haemoglobin Decreased, Melaena, Rectal Haemorrhage, Vaginal Haemorrhage, Rash Maculo-papular, Arthralgia
Adverse event was reported on Feb 14, 2014 by a Female taking Lansoprazole (Dosage: 30mg, 1x/day) was diagnosed with and. Location: GB , 34 years of age, weighting 220.0 lb, After Lansoprazole was administered, patient encountered several Lansoprazole side effects: purpura, haemorrhage, rash erythematous, haemoglobin decreased, melaena, rectal haemorrhage, vaginal haemorrhage, rash maculo-papular, arthralgia.
Multiple concurrent drugs taken:
  • Tranexamic Acid (1 Df, 4x/day)
  • Rituximab (375mg/m2, 2x/day)
  • Nplate (1mg/kg, Unk)
  • Dexamethasone
  • Immunoglobulin G Human (1000 Mg/kg, 1x/day)
  • Norethindrone (5mg, 3x/day)
  • Vincristine Sulfate
  • Anti-d Immunoglobulin
Patient was hospitalized.

Hepatitis Acute, Blood Cholesterol Increased, Gamma-glutamyltransferase Increased, Alanine Aminotransferase Increased
on Feb 04, 2014 Male from GB , 38 years of age, weighting 156.5 lb, was diagnosed with and was treated with Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: hepatitis acute, blood cholesterol increased, gamma-glutamyltransferase increased, alanine aminotransferase increased. Lansoprazole dosage: 15 Mg, Unk.
Associated medications used:

Gastric Mucosal Hypertrophy, Parietal Cell Antibody Positive
on Jan 23, 2014 Male from GB , 70 years of age, was treated with Lansoprazole. Patient felt the following Lansoprazole side effects: gastric mucosal hypertrophy, parietal cell antibody positive. Lansoprazole dosage: N/A.

Gastrooesophageal Heterotopia
Patient was taking Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: gastrooesophageal heterotopia on Jan 23, 2014 from GB Additional patient health information: Male , 67 years of age, . Lansoprazole dosage: N/A.

Ductal Adenocarcinoma Of Pancreas, Condition Aggravated
Adverse event was reported on Jan 14, 2014 by a Male taking Lansoprazole (Dosage: 15 Mg, Qd) was diagnosed with and. Location: JP , 66 years of age, weighting 147.7 lb, Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: ductal adenocarcinoma of pancreas, condition aggravated.
Associated medications used:
  • Blopress (4 Mg, 1 Days)
  • Actos (30 Mg, 1 Days)
  • Loxonin (60 Mg, 1 Days)
  • Nifedipine Cr (20 Mg, Mg)
  • Bezatol Sr (400 Mg, 1 Days)
  • Daonil (2.5 Mg, 1 Days)
  • Ts-1 /01593501/ (120 Mg, 1 Days)


Oesophageal Carcinoma, Condition Aggravated
on Jan 14, 2014 Male from JP , 81 years of age, weighting 70.55 lb, was diagnosed with and was treated with Lansoprazole. Patient felt the following Lansoprazole side effects: oesophageal carcinoma, condition aggravated. Lansoprazole dosage: 15 Mg, Qd.
Multiple prescriptions taken:
  • Loxonin (60 Mg, 1 Days)
  • Aldactone-a (50 Mg, 1 Days)
  • Mucosolvan (45 Mg, 1 Days)


Tetany, Hypomagnesaemia, Paraesthesia
on Jan 14, 2014 Male from GB , 60 years of age, was treated with Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: tetany, hypomagnesaemia, paraesthesia. Lansoprazole dosage: 30 Milligram Daily;.
Multiple concurrent drugs taken: Patient was hospitalized.

Tetany, Hypomagnesaemia, Paraesthesia, Hypocalcaemia
Patient was taking Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: tetany, hypomagnesaemia, paraesthesia, hypocalcaemia on Jan 13, 2014 from GB Additional patient health information: Male , 60 years of age, . Lansoprazole dosage: N/A.
Associated medications used: Patient was hospitalized.

Decreased Appetite, Abdominal Pain, Abnormal Dreams, Amnesia, Back Pain, Breast Tenderness, Cataract, Constipation, Diarrhoea
Adverse event was reported on Jan 03, 2014 by a Female taking Lansoprazole (Dosage: N/A) . Location: GB , 79 years of age, Patient felt the following Lansoprazole side effects: decreased appetite, abdominal pain, abnormal dreams, amnesia, back pain, breast tenderness, cataract, constipation, diarrhoea.
Multiple prescriptions taken: Patient was hospitalized.

Nikolsky^s Sign, Toxic Epidermal Necrolysis, Bacterial Infection
on Jan 10, 2014 Female from TR , 64 years of age, was treated with Lansoprazole. After Lansoprazole was administered, patient encountered several Lansoprazole side effects: nikolsky^s sign, toxic epidermal necrolysis, bacterial infection. Lansoprazole dosage: 30 Mg, Qd.
Multiple concurrent drugs taken: Patient was hospitalized.

Asthenia, Diarrhoea, Hypokalaemic Syndrome, Hyponatraemic Syndrome, Vomiting
on Jan 06, 2014 Female from IT , 86 years of age, was treated with Lansoprazole. Directly after, patient experienced the unwanted or unexpected Lansoprazole side effects: asthenia, diarrhoea, hypokalaemic syndrome, hyponatraemic syndrome, vomiting. Lansoprazole dosage: 30 Milligram Daily;. Patient was hospitalized.

Page 1 of 82 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Lansoprazole

Find Out How to Take Lansoprazole

Discuss Lansoprazole Side Effects

Did You Have a Lansoprazole Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Lansoprazole for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

Alternative LANSOPRAZOLE Names:LANSOPRAZ

Active Ingredient: LANSOPRAZ

More About Lansoprazole

Side Effects reported to FDA: 2036

Lansoprazole safety alerts: 2011

Reported deaths: 272

Reported hospitalizations: 1021

Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals - Clogged, Blocked Oral Syringes and Feeding Tubes

[Posted 04/15/2011]

AUDIENCE: Risk Manager, Pharmacy, Home Care

ISSUE: The FDA has received reports that Teva’s lansoprazole delayed-release orally disintegrating tablet has clogged and blocked oral syringes and feeding tubes, including both gastric and jejunostomy types, when the drug is administered as a suspension through these devices. The tablets may not fully disintegrate when water is added to them and/or they may disintegrate but later form clumps. These clumps can adhere to the inside walls of oral syringes and feeding tubes. In some cases, patients have had to seek emergency medical assistance and their feeding tubes have had to be unclogged or removed and replaced.

BACKGROUND: Lansoprazole is a proton pump inhibitor (PPI) medication. It is approved for the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis (EE), and Zollinger-Ellison Syndrome (a condition involving overproduction of stomach acid).

Teva Pharmaceuticals has voluntarily withdrawn its lansoprazole delayed-release ODT product from distribution at this time. However, some product may remain in stock in pharmacies and other facilities, and some patients may still have the product in their possession. The product may also be sold under the following labels: Sharp Corporation, Cardinal Health, and Quality Packaging Specialist, Inc.

RECOMMENDATIONS:

  • FDA recommends that healthcare professionals evaluate their medication stock and not dispense the Teva lansoprazole delayed-release ODT product to patients for whom the product will be administered through an oral syringe or feeding tube.
  • Patients and caregivers should be instructed not to administer the Teva lansoprazole delayed-release ODT product through oral syringes and/or feeding tubes due to the potential for clogging and blockage of the oral syringe or tube.
  • Read the Healthcare Professional Letter for other specific recommendations and for National Drug Code (NDC) numbers for the affected Teva products.

 

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

 

[04/15/2011 - Letter to Healthcare Professionals - FDA]
 

Latest Lansoprazole clinical trials